Cargando…
Therapeutic challenges in two adolescent male patients with Fabry disease and high antibody titres
Enzyme replacement therapy (ERT) has been shown to stabilize certain aspects of Fabry disease (FD). However, in some patients on ERT, high antibody titres have been documented, with limited clinical improvement in systemic manifestations and often with significant adverse drug reactions. We present...
Autores principales: | Mhanni, Aizeddin A., Auray-Blais, Christiane, Boutin, Michel, Johnston, Alie, LeMoine, Kaye, Patterson, Jill, Aerts, Johannes M.F.G., West, Michael L., Rockman-Greenberg, Cheryl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322173/ https://www.ncbi.nlm.nih.gov/pubmed/32612933 http://dx.doi.org/10.1016/j.ymgmr.2020.100618 |
Ejemplares similares
-
Mass Spectrometry Evaluation of Biomarkers in the Vitreous Fluid in Gaucher Disease Type 3 with Disease Progression Despite Long-Term Treatment
por: Mhanni, Aizeddin, et al.
Publicado: (2020) -
Prenatal onset of the neuroradiologic phenotype of pyruvate carboxylase deficiency due to homozygous PC c.1828G > A mutations
por: Mhanni, Aizeddin A., et al.
Publicado: (2021) -
Lentivirus-mediated gene therapy for Fabry disease
por: Khan, Aneal, et al.
Publicado: (2021) -
A novel WFS1 variant associated with isolated congenital cataracts
por: Krutish, Angela, et al.
Publicado: (2023) -
Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction
por: Yogasundaram, Haran, et al.
Publicado: (2018)